Clinical Trials
Study Title:
A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody Drug Conjugate MYTX 011 in Subjects with Non Small Cell Lung Cancer
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Mariam Alexander, at alexanma@musc.edu.
Study Coordinator, Jessica Shealor, at shealorj@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |